Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022

BUY
$4.88 - $8.56 $8.89 Million - $15.6 Million
1,822,501 Added 121.72%
3,319,800 $25.8 Million
Q4 2021

Feb 15, 2022

BUY
$7.03 - $13.03 $896,620 - $1.66 Million
127,542 Added 9.31%
1,497,299 $10.5 Million
Q3 2021

Nov 16, 2021

SELL
$11.11 - $17.84 $19 Million - $30.6 Million
-1,712,473 Reduced 55.56%
1,369,757 $15.5 Million
Q2 2021

Aug 16, 2021

SELL
$13.68 - $22.34 $10.5 Million - $17.1 Million
-766,470 Reduced 19.92%
3,082,230 $55.7 Million
Q1 2021

May 18, 2021

BUY
$9.0 - $63.91 $21.6 Million - $154 Million
2,403,700 Added 166.35%
3,848,700 $87.5 Million
Q4 2020

Feb 17, 2021

BUY
$4.82 - $10.1 $1.25 Million - $2.62 Million
259,100 Added 21.85%
1,445,000 $11.9 Million
Q3 2020

Nov 17, 2020

SELL
$4.7 - $8.7 $11.7 Million - $21.7 Million
-2,498,300 Reduced 67.81%
1,185,900 $5.75 Million
Q2 2020

Aug 17, 2020

SELL
$5.54 - $10.81 $2.68 Million - $5.23 Million
-483,800 Reduced 11.61%
3,684,200 $26.2 Million
Q1 2020

May 15, 2020

BUY
$2.47 - $21.36 $8.8 Million - $76.1 Million
3,563,000 Added 588.93%
4,168,000 $28.7 Million
Q4 2019

Feb 14, 2020

BUY
$15.72 - $24.88 $1.61 Million - $2.55 Million
102,600 Added 20.42%
605,000 $10.4 Million
Q3 2019

Nov 14, 2019

BUY
$24.74 - $49.3 $2.91 Million - $5.81 Million
117,800 Added 30.63%
502,400 $12.4 Million
Q2 2019

Aug 15, 2019

BUY
$34.66 - $63.73 $3.05 Million - $5.6 Million
87,900 Added 29.63%
384,600 $17.9 Million
Q1 2019

May 16, 2019

SELL
$64.85 - $100.15 $13.7 Million - $21.1 Million
-210,900 Reduced 41.55%
296,700 $19.4 Million
Q4 2018

Feb 15, 2019

BUY
$65.89 - $165.64 $12.7 Million - $31.8 Million
192,000 Added 60.84%
507,600 $35.8 Million
Q3 2018

Nov 14, 2018

BUY
$22.1 - $214.06 $6.97 Million - $67.6 Million
315,600 New
315,600 $45.3 Million

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $1.01B
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.